Clinical Takeaway Archives - Page 23 of 25

Clinical Takeaway

Earning CPD by listening to Healthed podcasts is simple. Each episode is eligible for Educational Activities CPD.

Filter results

Emergency medicine, Oral and dental

Clinical Takeaway

0.5 EA, 0.5 RP

Tackling trauma to lower third of the face

Altered sensation of lip and chin, an altered bite or malocclusion or change in tooth position are important signs of significant injury

Expert/s: Clinical A/Prof Dieter Gebauer

Diabetes and metabolism

Clinical Takeaway

1 EA, 0.5 RP

Lifestyle modification and T2D

When it comes to lifestyle modification in the management of T2DM, dietary intervention is by far the most important

Expert/s: Dr Paul Mason

Oral and dental

Clinical Takeaway

0.5 EA, 0.5 RP

Oral lumps and bumps

The red flags are lesions that are painful, rapidly expanding, bleeding, ulcerated and not of a homogenous appearance

Expert/s: Clinical A/Prof Dieter Gebauer

Diabetes and metabolism

Clinical Takeaway

0.5 EA, 0.5 RP

T2D and the heart

In this era of SGLT2 inhibitors and GLP1 agonists, we need to initiate these therapies early because of their cardioprotective and renoprotective (for SGLT2I) benefits

Expert/s: A/Prof Neale Cohen

Diabetes and metabolism

Clinical Takeaway

0.5 EA, 0.5 RP

T2D and the foot

The aim of the game in managing patients with T2DM is to keep them out of hospital; diabetic foot complications are a common and recurrent reason for patients to be admitted to hospitals

Expert/s: Prof Merlin Thomas

Genetics

Clinical Takeaway

0.5 EA, 0.5 RP

Epigenetic testing

The reality of epigenetic tests in general practice may not be that far away

Expert/s: Prof Jeffrey Craig

Diabetes and metabolism

Clinical Takeaway

0.5 EA, 0.5 RP

What’s in and what’s out in T2D management guidelines

The evidence for the use of SGLT2 inhibitors and GLP-1a is increasing and practical tips for GPs to help us in managing patients with T2DM

Expert/s: Dr Gary Deed

Psychiatry

Clinical Takeaway

0.5 EA, 0.5 RP

Free ‘staff’ for professionals treating suicidal patients

When someone is suicidal, those who are close to the distressed person do not know what to do and often feel paralysed - because they are not sure what is the right thing to say

Expert/s: Dr David Horgan

Respiratory and sleep

Clinical Takeaway

0.5 EA, 0.5 RP

Oral prednisone, asthma and osteoporosis risk

If needed, oral prednisone should still be used but do so judiciously and keep in mind that the risk of osteoporosis is directly linked to cumulative lifetime doses of oral steroid

Expert/s: Prof Peter Wark

Diabetes and metabolism

Clinical Takeaway

0.5 EA, 0.5 RP

A practical approach to first, second and third line treatment

In the patient with newly diagnosed T2DM without micro or macrovascular complications, achieving good glycaemic control is important and this together with an eye to avoiding weight gain and hypoglycaemia will drive your choice of a second-line agent

Expert/s: Dr Anita Sharma

Neurology

Clinical Takeaway

0.5 EA, 0.5 RP

Chronic vestibular syndromes – Part 3

Recurrent vertigo, recurrent spontaneous vertigo, imbalance ataxia and persistent postural perceptual dizziness (PPPD)

Expert/s: Dr Benjamin Tsang

Diabetes and metabolism

Clinical Takeaway

0.5 EA, 0.5 RP

T2D and the kidney

CKD is a marker of poor prognosis and if present, we must work hard to prevent adverse outcomes… now is the time for SGLT2i, statins, ace inhibitors, and arbs

Expert/s: Prof Merlin Thomas

Tackling trauma to lower third of the face

Altered sensation of lip and chin, an altered bite or malocclusion or change in tooth position are important signs of significant injury

Expert/s: Clinical A/Prof Dieter Gebauer

Clinical Takeaway

Emergency medicine, Oral and dental

Lifestyle modification and T2D

When it comes to lifestyle modification in the management of T2DM, dietary intervention is by far the most important

Expert/s: Dr Paul Mason

Clinical Takeaway

Diabetes and metabolism

Oral lumps and bumps

The red flags are lesions that are painful, rapidly expanding, bleeding, ulcerated and not of a homogenous appearance

Expert/s: Clinical A/Prof Dieter Gebauer

Clinical Takeaway

Oral and dental

T2D and the heart

In this era of SGLT2 inhibitors and GLP1 agonists, we need to initiate these therapies early because of their cardioprotective and renoprotective (for SGLT2I) benefits

Expert/s: A/Prof Neale Cohen

Clinical Takeaway

Diabetes and metabolism

T2D and the foot

The aim of the game in managing patients with T2DM is to keep them out of hospital; diabetic foot complications are a common and recurrent reason for patients to be admitted to hospitals

Expert/s: Prof Merlin Thomas

Clinical Takeaway

Diabetes and metabolism

Epigenetic testing

The reality of epigenetic tests in general practice may not be that far away

Expert/s: Prof Jeffrey Craig

Clinical Takeaway

Genetics

What’s in and what’s out in T2D management guidelines

The evidence for the use of SGLT2 inhibitors and GLP-1a is increasing and practical tips for GPs to help us in managing patients with T2DM

Expert/s: Dr Gary Deed

Clinical Takeaway

Diabetes and metabolism

Free ‘staff’ for professionals treating suicidal patients

When someone is suicidal, those who are close to the distressed person do not know what to do and often feel paralysed - because they are not sure what is the right thing to say

Expert/s: Dr David Horgan

Clinical Takeaway

Psychiatry

Oral prednisone, asthma and osteoporosis risk

If needed, oral prednisone should still be used but do so judiciously and keep in mind that the risk of osteoporosis is directly linked to cumulative lifetime doses of oral steroid

Expert/s: Prof Peter Wark

Clinical Takeaway

Respiratory and sleep

A practical approach to first, second and third line treatment

In the patient with newly diagnosed T2DM without micro or macrovascular complications, achieving good glycaemic control is important and this together with an eye to avoiding weight gain and hypoglycaemia will drive your choice of a second-line agent

Expert/s: Dr Anita Sharma

Clinical Takeaway

Diabetes and metabolism

Chronic vestibular syndromes – Part 3

Recurrent vertigo, recurrent spontaneous vertigo, imbalance ataxia and persistent postural perceptual dizziness (PPPD)

Expert/s: Dr Benjamin Tsang

Clinical Takeaway

Neurology

T2D and the kidney

CKD is a marker of poor prognosis and if present, we must work hard to prevent adverse outcomes… now is the time for SGLT2i, statins, ace inhibitors, and arbs

Expert/s: Prof Merlin Thomas

Clinical Takeaway

Diabetes and metabolism

Clinical Takeaway

Filter results

Altered sensation of lip and chin, an altered bite or malocclusion or change in tooth position are important signs of significant injury

When it comes to lifestyle modification in the management of T2DM, dietary intervention is by far the most important

The red flags are lesions that are painful, rapidly expanding, bleeding, ulcerated and not of a homogenous appearance

In this era of SGLT2 inhibitors and GLP1 agonists, we need to initiate these therapies early because of their cardioprotective and renoprotective (for SGLT2I) benefits

The aim of the game in managing patients with T2DM is to keep them out of hospital; diabetic foot complications are a common and recurrent reason for patients to be admitted to hospitals

The reality of epigenetic tests in general practice may not be that far away

The evidence for the use of SGLT2 inhibitors and GLP-1a is increasing and practical tips for GPs to help us in managing patients with T2DM

When someone is suicidal, those who are close to the distressed person do not know what to do and often feel paralysed - because they are not sure what is the right thing to say

If needed, oral prednisone should still be used but do so judiciously and keep in mind that the risk of osteoporosis is directly linked to cumulative lifetime doses of oral steroid

In the patient with newly diagnosed T2DM without micro or macrovascular complications, achieving good glycaemic control is important and this together with an eye to avoiding weight gain and hypoglycaemia will drive your choice of a second-line agent

Recurrent vertigo, recurrent spontaneous vertigo, imbalance ataxia and persistent postural perceptual dizziness (PPPD)

CKD is a marker of poor prognosis and if present, we must work hard to prevent adverse outcomes… now is the time for SGLT2i, statins, ace inhibitors, and arbs

Altered sensation of lip and chin, an altered bite or malocclusion or change in tooth position are important signs of significant injury

When it comes to lifestyle modification in the management of T2DM, dietary intervention is by far the most important

The red flags are lesions that are painful, rapidly expanding, bleeding, ulcerated and not of a homogenous appearance

In this era of SGLT2 inhibitors and GLP1 agonists, we need to initiate these therapies early because of their cardioprotective and renoprotective (for SGLT2I) benefits

The aim of the game in managing patients with T2DM is to keep them out of hospital; diabetic foot complications are a common and recurrent reason for patients to be admitted to hospitals

The reality of epigenetic tests in general practice may not be that far away

The evidence for the use of SGLT2 inhibitors and GLP-1a is increasing and practical tips for GPs to help us in managing patients with T2DM

When someone is suicidal, those who are close to the distressed person do not know what to do and often feel paralysed - because they are not sure what is the right thing to say

If needed, oral prednisone should still be used but do so judiciously and keep in mind that the risk of osteoporosis is directly linked to cumulative lifetime doses of oral steroid

In the patient with newly diagnosed T2DM without micro or macrovascular complications, achieving good glycaemic control is important and this together with an eye to avoiding weight gain and hypoglycaemia will drive your choice of a second-line agent

Recurrent vertigo, recurrent spontaneous vertigo, imbalance ataxia and persistent postural perceptual dizziness (PPPD)

CKD is a marker of poor prognosis and if present, we must work hard to prevent adverse outcomes… now is the time for SGLT2i, statins, ace inhibitors, and arbs

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.